Safety and Efficacy of Azacitidine and Chidamide Maintenance after Allogeneic Hematopoietic Stem Cell Transplantation for Patients with High-Risk Acute Myeloid Leukemia: Interim Analysis of a Prospective, Multicenter, Single-Arm, Phase II Clinical Trial

被引：0
|
作者：
Yang, Chuting [1 ]
Zheng, Yaling [1 ]
Song, Chaoyang [2 ]
Wu, Ming [1 ]
Wang, Lei [1 ]
Zhou, Xuan [1 ]
Yue, Chunyan [1 ]
Lin, Xiaonan [1 ]
Chen, Jie [3 ]
Zeng, Hui [3 ]
Huang, Rui [1 ]
Li, Yuhua [2 ]
机构：
[1] Southern Med Univ, Dept Hematol, Zhujiang Hosp, Guangzhou, Peoples R China
[2] Southern Med Univ, Zhujiang Hosp, Dept Hematol, Guangzhou, Peoples R China
[3] Jinan Univ, Dept Hematol, Affiliated Hosp 1, Guangzhou, Peoples R China
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-174879
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [41] Efficacy and Safety of Blinatumomab As Maintenance Therapy in Patients with High-Risk B-Lineage Acute Lymphoblastic Leukemia Post Allogeneic Hematopoietic Cell Transplantation
    Zhang, Tingting
    Liu, Li
    Zheng, Xiaohui
    Shen, Biao
    Gong, Ming
    Liu, Xin
    Li, Gang
    Zhang, Ying
    Cao, Wenbin
    Liang, Chen
    Pang, Aiming
    He, Yi
    Yang, Donglin
    Feng, Sizhou
    Han, Mingzhe
    Jiang, Erlie
    BLOOD, 2024, 144 : 2828 - 2828
  • [42] Efficacy and Safety in Early application of Ruxolinitib for high-risk: Acute lymphoblastic leukemia to prevent GVHD and recurrence after allogeneic hematopoietic stem cell transplantation
    Cheng, Qian
    Tang, Yishu
    Liu, Feiyang
    Li, Xin
    Fang, Dan
    TRANSPLANT IMMUNOLOGY, 2024, 83
  • [43] Efficacy and Safety of Hetrombopag in Promoting Platelet Engraftment after Allogeneic Hematopoietic Stem Cell Transplantation: A Prospective, Multicenter, Randomized Controlled Clinical Trial
    Feng, Yimei
    Wang, Linhui
    Lang, Tao
    Ren, Mingqiang
    Yi, Hai
    Deng, Jianchuan
    Ma, Liangliang
    Xing, Hongyun
    Wang, Dan
    Yao, Han
    Chen, Ting
    Liu, Yuqing
    Zhu, Lidan
    Liu, Jia
    Gao, Shichun
    Gao, Lei
    Zhang, Xi
    BLOOD, 2023, 142
  • [44] Efficacy of minimal residual disease driven immune-intervention after allogeneic hematopoietic stem cell transplantation for high-risk chronic lymphocytic leukemia: results of a prospective multicenter trial
    Tournilhac, Olivier
    Le Garff-Tavernier, Magali
    Quoc, Stephanie Nguyen
    Forcade, Edouard
    Chevallier, Patrice
    Legrand-Izadifar, Faezeh
    Damaj, Gandhi Laurent
    Michonneau, David
    Tomowiak, Cecile
    Borel, Cecile
    Orvain, Corentin
    Turlure, Pascal
    Redjou, Rabah
    Guillerm, Gaelle
    Vincent, Laure
    Simand, Celestine
    Lemal, Richard
    Quiney, Claire
    Combes, Patricia
    Pereira, Bruno
    Calvet, Laure
    Cabrespine, Aurelie
    Bay, Jacques-Olivier
    Leblond, Veronique
    Dhedin, Nathalie
    HAEMATOLOGICA, 2021, 106 (07) : 1867 - 1875
  • [45] Phase II Multicenter trial to evaluate the safety and efficacy of low-toxicity treosulfan/fludarabine conditioning prior to allogeneic haematopoietic stem cell transplantation in patients with acute myeloid leukemia
    Holowiecki, Jerzy
    Giebel, S.
    Beelen, D.
    Trenschel, R.
    Wandt, H.
    Schaefer-Eckart, K.
    Ruutu, T.
    Volin, L.
    Einsele, H.
    Stuhler, G.
    Uharek, L.
    Blau, I.
    Bornhaeuser, M.
    Zander, A.
    Kroeger, N.
    Aschan, J.
    Wojnar, J.
    Markiewicz, J.
    Freund, M.
    Casper, J.
    BLOOD, 2007, 110 (11) : 192A - 192A
  • [46] Interim Results from a Phase 2, Multicenter, Single-Arm Study to Evaluate the Safety and Efficacy of Deferasirox after Hematopoietic Stem Cell Transplantation in Children with Beta-Thalassemia Major
    Yesilipek, M. Akif
    Karasu, Gulsun
    Kaya, Zuhre
    Kuskonmaz, Baris B.
    Uygun, Vedat
    Dag, Ilkiz
    Birkent, Asli
    Ertem, Mehmet
    BLOOD, 2015, 126 (23)
  • [47] Feasibility and safety of Venetoclax-based bridging to allogeneic Hematopoietic Stem Cell Transplantation (alloHCT) for high-risk Acute Myeloid Leukemia (AML)
    Pabst, C.
    Sauer, T.
    Stadtherr, P.
    Hegenbart, U.
    Luft, T.
    Hundemer, M.
    Schlenk, R. F.
    Mueller-Tidow, C.
    Dreger, P.
    ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 (SUPPL 4) : 51 - 51
  • [48] Venetoclax Plus Decitabine for Young Adults with Newly Diagnosed ELN Adverse-Risk Acute Myeloid Leukemia: Interim Analysis of a Prospective, Multicenter, Single-Arm, Phase 2 Trial
    Chen, Suning
    Xie, Jundan
    Yang, Xiaofei
    Shen, Hongjie
    Cen, Jiannong
    Yao, Li
    Hu, Xiaohui
    Wu, Qian
    Zhang, Jingren
    Qiu, Hongchun
    Tang, Xiaowen
    Sun, Aining
    Xue, Shengli
    Wang, Ying
    Qiu, Huiying
    Wu, Depei
    BLOOD, 2021, 138
  • [49] Allogeneic Hematopoietic Stem Cell Transplantation in Adolescent and Adult Patients with High-Risk T Cell Acute Lymphoblastic Leukemia
    Bakr, Mohammad
    Rasheed, Walid
    Mohamed, Said Y.
    Al-Mohareb, Fahad
    Chaudhri, Naeem
    Al-Sharif, Fahad
    Al-Zahrani, Hazza
    Al-Dawsari, Ghuzayel
    Saleh, Abu Jafar
    Nassar, Amr
    Ahmed, Shad
    Elghazaly, Assem
    Ahmed, Syed O.
    Ibrahim, Khalid
    Chebbo, Wahiba
    El Gohary, Ghada M.
    Al Mahayni, Muhamad H.
    Hussain, Fazal
    Nurgat, Zubeir
    Elhassan, Tusneem Ahmed
    Walter, Claudia U.
    Aljurf, Mahmoud
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2012, 18 (12) : 1897 - 1904
  • [50] Azacitidine and lenalidomide combination: a novel relapse prophylaxis regimen after allogeneic hematopoietic stem-cell transplantation in patients with acute myeloid leukemia
    Feng, Yimei
    Chen, Ting
    Zhang, Yun
    Yao, Han
    Wang, Ping
    Wang, Lu
    Cassady, Kaniel
    Zou, Zhongmin
    Liu, Yuqing
    Zhao, Lu
    Gao, Lei
    Zhang, Xi
    Kong, Peiyan
    FRONTIERS IN IMMUNOLOGY, 2023, 14
12345